Kleanthis Xanthopoulos

Kleanthis Xanthopoulos

Director/Board Member at CONNECT BIOPHARMA HOLDINGS LIMITED

Net worth: - $ as of 2024-03-30

66 year
Health Technology
Commercial Services
Finance

Profile

Kleanthis G.
Xanthopoulos
is the founder of Anadys Pharmaceuticals, Inc. (founded in 1992) and SENTÉ, Inc. (California) (founded in 2007).
He is also the founder of SENTÉ Labs (founded in 2007).
Dr. Xanthopoulos is also the founder of Shoreline Biosciences, Inc. Dr. Xanthopoulos's current job(s) include Chairman at Stork Capital SARL (since 2020), Director at Irras AB (since 2015), Director at Suzhou Connect Biopharma Co. Ltd.
(since 2020), Lead Independent Director at Connect Biopharma Holdings Ltd.
(since 2020), President at Helios, Inc., Member-Executive Board at BIOCOM, and Managing Partner at Vandel Group LLC.
Dr. Xanthopoulos's former job(s) include President, Chief Executive Officer & Director at Regulus Therapeutics, Inc. (2007-2015), Chairman at Apricus Biosciences, Inc. (2011-2019), Chairman at Bioniz Therapeutics, Inc. (2015-2016), Director at ZP Opco, Inc., Director at Biotechnology Innovation Organization, Director at J.E.M.
Capital, Inc. (2013-2014), Managing Director at Enterprise Partners Venture Capital (2007), Director at Odyssey Thera, Inc., Director at Aspirus, Inc., Director at Laboratori Derivati Organici SpA (2016-2017), Independent Director at Zosano Pharma Corp.
(2013-2021), Senior Vice President at Ionis Pharmaceuticals, Inc., Vice President-Genomics & Molecular Biology at Aurora Biosciences Corp.
(1997-2000), Associate Professor at Karolinska Institutet, Section Head at National Human Genome Research Institute (1995-1997), and Managing General Partner at Cerus Advisors DMCC (2015-2020).
Dr. Xanthopoulos's education includes a doctorate degree from the University of Stockholm (1986), a graduate degree from the University of Stockholm (1982), and an undergraduate degree from Aristotle University of Thessaloniki (1980).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-02-28 0 ( -.--% ) - $ 2024-03-30

Kleanthis Xanthopoulos active positions

CompaniesPositionStart
IRRAS AB Director/Board Member 2015-05-31
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 2020-11-30
Stork Capital SARL Chairman 2020-05-31
Director/Board Member 2020-10-31
Chief Executive Officer -
President -
Vandel Group LLC Corporate Officer/Principal -
Founder 2006-12-31
Corporate Officer/Principal 2014-07-28
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
All active positions of Kleanthis Xanthopoulos

Former positions of Kleanthis Xanthopoulos

CompaniesPositionEnd
░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
See the detail of Kleanthis Xanthopoulos's experience

Training of Kleanthis Xanthopoulos

University of Stockholm Graduate Degree
Aristotle University of Thessaloniki Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kleanthis Xanthopoulos's experience

Connections

100 +

1st degree connections

29

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
IONIS PHARMACEUTICALS, INC.

Health Technology

REGULUS THERAPEUTICS INC.

Health Technology

IRRAS AB

Health Technology

CONNECT BIOPHARMA HOLDINGS LIMITED

Health Technology

Private companies22

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Finance

Health Technology

Commercial Services

Health Services

Health Technology

Government

Retail Trade

Vandel Group LLC

Finance

Health Technology

Stork Capital SARL

Health Technology

SENTÉ Labs

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Kleanthis Xanthopoulos